BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9

• Press Releases

  Tango Therapeutics Announces Proposed $500 Million Public Offering

  June 9, 2026

   · 

  4 min read
• Press Releases

  Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders

  June 9, 2026

   · 

  3 min read
• Press Releases

  IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2026

  June 9, 2026

   · 

  1 min read
• Press Releases

  JCR Pharmaceuticals’ Research Presentations at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders

  June 9, 2026

   · 

  13 min read
• Press Releases

  Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA® (valbenazine) Capsules Across a Broad Range of Patients

  June 9, 2026

   · 

  15 min read
• Press Releases

  Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium

  June 9, 2026

   · 

  8 min read
• Press Releases

  insitro Presents New Data Demonstrating Its AI-Discovered MASH Candidate Shows Anti-Fibrotic Signal Beyond Liver-Fat Reduction at the American Diabetes Association 86th Scientific Sessions

  June 9, 2026

   · 

  6 min read
• Press Releases

  City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics

  June 9, 2026

   · 

  3 min read
• Press Releases

  Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study

  June 9, 2026

   · 

  19 min read
• Press Releases

  Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

  June 9, 2026

   · 

  8 min read